A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma

Project: Research

Project Details

StatusActive
Effective start/end date21/08/20 → 20/08/25

Keywords

  • clinical trial
  • lymphoma
  • treatment efficacy
  • phase 1 study